The influence of CD4 T-cell subsets on control of CD4 T-cell-mediated graft-versus-host disease

Immunology

Volumn 125, Issue 4, 2008, Pages 459-468

  Moncrieffe, Halima ^a,b   Coles, Mark ^a,c   Stockinger, Brigitta ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

CD4; Graft versus host disease; Regulation

Indexed keywords

CD134 ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; IMMUNOREGULATION; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEREOMICROSCOPY; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD44; CD4-POSITIVE T-LYMPHOCYTES; DNA-BINDING PROTEINS; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; IMMUNOLOGIC MEMORY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, ANIMAL; RECEPTORS, OX40; T-LYMPHOCYTE SUBSETS;

EID: 55449090373     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.02866.x     Document Type: Article

References (57)

1. + T cells. J Exp Med 2005 202 : 907 12.
2. Mackall CL, Bare CV, Granger LA, Sharrow SO, Titus JA, Gress RE. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol 1996 156 : 4609 16.
3. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001 2 : 816 22.
4. Barthlott T, Kassiotis G, Stockinger B. T cell regulation as a side effect of homeostasis and competition. J Exp Med 2003 197 : 451 60.
5. Bourgeois C, Kassiotis G, Stockinger B. A major role for memory CD4 T cells in the control of lymphopenia-induced proliferation of naive CD4 T cells. J Immunol 2005 174 : 5316 23.
6. Kolb HJ, Schmid C, Barrett AJ, Schendel DJ. Graft-versus-leukemia reactions in allogeneic chimeras. Blood 2004 103 : 767 76.
7. Dazzi F, Goldman J. Donor lymphocyte infusions. Curr Opin Hematol 1999 6 : 394 9.
8. Troeger A, Meisel R, Moritz T, Dilloo D. Immunotherapy in allogeneic hematopoietic stem cell transplantation - not just a case for effector cells. Bone Marrow Transplant 2005 35 (Suppl. 1 S59 64.
9. Simpson E, Scott D, James E et al. Minor H antigens: genes and peptides. Transpl Immunol 2002 10 : 115 23.
10. Blazar BR, Korngold R, Vallera DA. Recent advances in graft-versus-host disease (GVHD) prevention. Immunol Rev 1997 157 : 79 109.
11. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today 1998 19 : 395 404.
12. Rolink AG, Radaszkiewicz T, Pals ST, van der Meer WG, Gleichmann E. Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. I. Alloreactive suppressor cells rather than killer T cells appear to be the decisive effector cells in lethal graft-vs.-host disease. J Exp Med 1982 155 : 1501 22.
13. + T cells. J Immunol 1995 155 : 2396 406.
14. Tschetter JR, Mozes E, Shearer GM. Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease. J Immunol 2000 165 : 5987 94.
15. Flynn S, Toellner KM, Raykundalia C, Goodall M, Lane P. CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J Exp Med 1998 188 : 297 304.
16. Maxwell JR, Weinberg A, Prell RA, Vella AT. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion. J Immunol 2000 164 : 107 12.
17. Pippig SD, Pena-Rossi C, Long J et al. Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40). J Immunol 1999 163 : 6520 9.
18. Veiga-Fernandes H, Coles MC, Foster KE et al. Tyrosine kinase receptor RET is a key regulator of Peyer's patch organogenesis. Nature 2007 446 : 547 51.
19. de Boer J, Williams A, Skavdis G et al. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur J Immunol 2003 33 : 314 25.
20. Stetson DB, Mohrs M, Reinhardt RL et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med 2003 198 : 1069 76.
21. Zhu J, Min B, Hu-Li J et al. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat Immunol 2004 5 : 1157 65.
22. Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM, Costantini F. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 2001 1 : 4.
23. + T cells do not induce graft-versus-host disease. J Clin Invest 2003 112 : 101 8.
24. Chen BJ, Deoliveira D, Cui X, Le NT, Son J, Whitesides JF, Chao NJ. Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse. Blood 2007 109 : 3115 23.
25. - memory T cells without graft-versus-host disease. Blood 2004 103 : 1534 41.
26. Beilhack A, Schulz S, Baker J et al. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood 2005 106 : 1113 22.
27. Zhang Y, Joe G, Hexner E, Zhu J, Emerson SG. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease. J Immunol 2005 174 : 3051 8.
28. Dutt S, Tseng D, Ermann J et al. Naive and memory T cells induce different types of graft-versus-host disease. J Immunol 2007 179 : 6547 54.
29. Antin JH, Ferrara JL. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992 80 : 2964 8.
30. Joffre O, van Meerwijk JP. CD4(+)CD25(+) regulatory T lymphocytes in bone marrow transplantation. Semin Immunol 2006 18 : 128 35.
31. Weinberg AD, Vella AT, Croft M. OX-40: life beyond the effector T cell stage. Semin Immunol 1998 10 : 471 80.
32. Gramaglia I, Jember A, Pippig SD, Weinberg AD, Killeen N, Croft M. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J Immunol 2000 165 : 3043 50.
33. Rogers PR, Song J, Gramaglia I, Killeen N, Croft M. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity 2001 15 : 445 55.
34. Lane P. Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in T helper (Th)1 and Th2 cells. J Exp Med 2000 191 : 201 6.
35. Tsukada N, Akiba H, Kobata T, Aizawa Y, Yagita H, Okumura K. Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation. Blood 2000 95 : 2434 9.
36. Blazar BR, Sharpe AH, Chen AI et al. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients. Blood 2003 101 : 3741 8.
37. Maeda Y, Tawara I, Teshima T et al. Lymphopenia-induced proliferation of donor T cells reduces their capacity for causing acute graft-versus-host disease. Exp Hematol 2007 35 : 274 86.
38. + T cells mediate graft-versus-leukemia without inducing graft-versus-host disease. Blood 2008 111 : 2476 84.
39. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005 22 : 329 41.
40. + regulatory T cells in hematopoietic stem cell transplantation. Curr Top Microbiol Immunol 2005 293 : 265 85.
41. + T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 2004 104 : 3804 12.
42. + regulatory T cells protects from lethal acute GVHD. Blood 2005 105 : 2220 6.
43. Beilhack A, Schulz S, Baker J et al. Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs. Blood 2008 111 : 2919 28.
44. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002 196 : 389 99.
45. + T cells. J Exp Med 1996 183 : 2669 74.
46. + T cells. J Immunol 2006 176 : 6202 10.
47. Gramaglia I, Weinberg AD, Lemon M, Croft M. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J Immunol 1998 161 : 6510 7.
48. Burgess JK, Blake AE, Boustany S et al. CD40 and OX40 ligand are increased on stimulated asthmatic airway smooth muscle. J Allergy Clin Immunol 2005 115 : 302 8.
49. Curry AJ, Chikwe J, Smith XG, Cai M, Schwarz H, Bradley JA, Bolton EM. OX40 (CD134) blockade inhibits the co-stimulatory cascade and promotes heart allograft survival. Transplantation 2004 78 : 807 14.
50. Humphreys IR, Walzl G, Edwards L, Rae A, Hill S, Hussell T. A critical role for OX40 in T cell-mediated immunopathology during lung viral infection. J Exp Med 2003 198 : 1237 42.
51. Hattori T, Usui Y, Okunuki Y et al. Blockade of the OX40 ligand prolongs corneal allograft survival. Eur J Immunol 2007 37 : 3597 604.
52. Valzasina B, Guiducci C, Dislich H, Killeen N, Weinberg AD, Colombo MP. Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. Blood 2005 105 : 2845 51.
53. + Tregs. Blood 2007 110 : 2501 10.
54. + T cells. J Immunol 2007 179 : 1427 30.
55. + CD25 T cells via p53, IL-2, and OX40. Proc Natl Acad Sci USA 2007 104 : 15478 83.
56. + regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur J Immunol 2002 32 : 3267 75.
57. + T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999 163 : 5211 8.